Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17866314 | 0.79 | HDAC9 (0.36) | — | |
| SCHEMBL9720104 | 0.77 | SLC6A3 (0.35) | — | |
| SCHEMBL11822773 | 0.76 | HDAC1 (0.34) | — | |
| SCHEMBL11820715 | 0.68 | NPC1 (0.36) | MAOBMAOA | |
| SCHEMBL276639 | 0.67 | HDAC4 (0.32) | — | |
| SCHEMBL29223962 | 0.67 | CA1 (0.33) | — | |
| SCHEMBL6485450 | 0.66 | — | — | |
| SCHEMBL8449213 | 0.66 | — | — | |
| SCHEMBL6999700 | 0.64 | NPY5R (0.30) | — | |
| SCHEMBL31123505 | 0.63 | MAOB (0.32) | MAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110746983-B | Achiral side methyl alkyl terphenyl liquid crystal compound, preparation method, liquid crystal composition and application | 武汉轻工大学 | 2021-09-17 | — | — | CN | disclosed |
| CN-110746983-A | Achiral side methyl alkyl terphenyl liquid crystal compound, preparation method, liquid crystal composition and application | 武汉轻工大学 | 2020-02-04 | — | — | CN | disclosed |
| US-7119203-B2 | Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors | PHARMACIA CORPORATION (US) | 2006-10-10 | — | — | US | disclosed |
| US-20050209278-A1 | Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors | PHARMACIA CORPORATION | 2005-09-22 | — | — | US | disclosed |
| US-20050009838-A1 | Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors | PHARMACIA CORPORATION | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050209278-A1 | Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors | MMP1, PREP, MMP3 | MAOB 1252/4885MAOA 500/4885 |
| US-20050009838-A1 | Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors | MMP1, PREP, MMP3 | MAOB 1252/4885MAOA 500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.